loadpatents
Patent applications and USPTO patent grants for ASHCRAFT; Luke W..The latest application filed is for "cardiac sarcomere inhibitors".
Patent | Date |
---|---|
Cardiac Sarcomere Inhibitors App 20220306642 - MORGAN; Bradley P. ;   et al. | 2022-09-29 |
Cardiac sarcomere inhibitors Grant 11,414,424 - Chuang , et al. August 16, 2 | 2022-08-16 |
Cardiac Sarcomere Inhibitors App 20210147399 - CHUANG; Chihyuan ;   et al. | 2021-05-20 |
Cardiac sarcomere inhibitors Grant 10,836,755 - Chuang , et al. November 17, 2 | 2020-11-17 |
Cardiac Sarcomere Inhibitors App 20200109148 - CHUANG; Chihyuan ;   et al. | 2020-04-09 |
Cardiac Sarcomere Inhibitors App 20190256504 - CHUANG; Chihyuan ;   et al. | 2019-08-22 |
Substituted pyridazines as skeletal muscle modulators Grant 10,076,519 - Ashcraft , et al. September 18, 2 | 2018-09-18 |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use Grant 9,994,528 - Ashcraft , et al. June 12, 2 | 2018-06-12 |
Substituted Pyridazines As Skeletal Muscle Modulators App 20170281621 - ASHCRAFT; Luke W. ;   et al. | 2017-10-05 |
Substituted pyridazines as skeletal muscle modulators Grant 9,604,965 - Ashcraft , et al. March 28, 2 | 2017-03-28 |
Certain Heterocycles, Compositions Thereof, And Methods For Their Use App 20160289211 - ASHCRAFT; Luke W. ;   et al. | 2016-10-06 |
Certain heterocycles, compositions thereof, and methods for their use Grant 9,278,962 - Ashcraft , et al. March 8, 2 | 2016-03-08 |
Certain Amino-pyridazines, Compositions Thereof, And Methods For Their Use App 20150322018 - Ashcraft; Luke W. ;   et al. | 2015-11-12 |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use Grant 9,133,123 - Ashcraft , et al. September 15, 2 | 2015-09-15 |
Amino-pyridazine skeletal muscle modulators Grant 8,969,346 - Ashcraft , et al. March 3, 2 | 2015-03-03 |
Certain Heterocycles, Compositions Thereof, And Methods For Their Use App 20140330011 - Ashcraft; Luke W. ;   et al. | 2014-11-06 |
Imidazole-benzamide anti-cancer agents Grant 8,772,507 - Qian , et al. July 8, 2 | 2014-07-08 |
Certain heterocycles, compositions thereof, and methods for their use Grant 8,759,380 - Ashcraft , et al. June 24, 2 | 2014-06-24 |
Certain heterocycles, compositions thereof, and methods for their use Grant 8,686,007 - Ashcraft , et al. April 1, 2 | 2014-04-01 |
Certain Amino-pyridines And Amino-triazines, Compositions Thereof, And Methods For Their Use App 20130150368 - Ashcraft; Luke W. ;   et al. | 2013-06-13 |
Certain Amino-pyridazines, Compositions Thereof, And Methods Of Their Use App 20130143862 - Ashcraft; Luke W. ;   et al. | 2013-06-06 |
Certain Chemical Entities, Compositions And Methods App 20130096315 - Qian; Xiangping ;   et al. | 2013-04-18 |
Certain Heterocycles, Compositions Thereof, And Methods For Their Use App 20130060025 - Ashcraft; Luke W. ;   et al. | 2013-03-07 |
Certain Heterocycles, Compositions Thereof, And Methods For Their Use App 20120289698 - Ashcraft; Luke W. ;   et al. | 2012-11-15 |
Certain Chemical Entities, Compositions, And Methods App 20120283287 - Qian; Xiangping ;   et al. | 2012-11-08 |
Imidazopyridinyl benzamide mitotic kinesin inhibitors Grant 8,207,340 - Qian , et al. June 26, 2 | 2012-06-26 |
Imidazopyridinyl benzamide mitotic kinesin inhibitors Grant 8,163,919 - Qian , et al. April 24, 2 | 2012-04-24 |
Certain Chemical Entities, Compositions And Methods App 20110312975 - Yang; Zhe ;   et al. | 2011-12-22 |
Certain chemical entities, compositions, and methods Grant 7,989,469 - Yang , et al. August 2, 2 | 2011-08-02 |
Certain chemical entities, compositions, and methods Grant 7,851,484 - Morgan , et al. December 14, 2 | 2010-12-14 |
Imidazoyl-benzamide anti-cancer agents Grant 7,795,448 - Qian , et al. September 14, 2 | 2010-09-14 |
Certain Chemical Entities, Compositions, and Methods App 20100069453 - Qian; Xiangping ;   et al. | 2010-03-18 |
Certain Chemical Entities, Compositions, and Methods App 20090312365 - Qian; Xiangping ;   et al. | 2009-12-17 |
Certain Chemical Entities, Compositions and Methods App 20090306127 - Qian; Xiangping ;   et al. | 2009-12-10 |
Certain Chemical Entities, Compositions, And Methods App 20090286841 - QIAN; Xiangping ;   et al. | 2009-11-19 |
Imidazopyridinyl-benzamide anti-cancer agents Grant 7,618,981 - Qian , et al. November 17, 2 | 2009-11-17 |
Certain Chemical Entities, Compositions, And Methods App 20090253737 - YANG; Zhe ;   et al. | 2009-10-08 |
Imidazoyl-benzamide anti-cancer agents Grant 7,582,668 - Qian , et al. September 1, 2 | 2009-09-01 |
Certain chemical entities, compositions, and methods App 20080255182 - Qian; Xiangping ;   et al. | 2008-10-16 |
Certain Chemical Entities, Compositions, and Methods App 20080242695 - Morgan; Bradley P. ;   et al. | 2008-10-02 |
Certain chemical entities, compositions, and methods App 20070197481 - Qian; Xiangping ;   et al. | 2007-08-23 |
Certain chemical entities, compositions, and methods App 20070149516 - Qian; Xiangping ;   et al. | 2007-06-28 |
Certain chemical entities, compositions, and methods App 20060247289 - Qian; Xiangping ;   et al. | 2006-11-02 |
Certain chemical entities, compositions, and methods App 20060094708 - Qian; Xiangping ;   et al. | 2006-05-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.